Medtecs International

Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
#1
Rainbow 
3Q result as at 30 Sep 2020
Revenues      USD287m (vs  50m)
Gross Profit  USD116m (vs  7m)
Net Profit    USD 84m (vs 0.4m)

Critical success factors

(1) Implementation of the "Source and Sell Globally" strategy to provide one-stop, bundled services to meet our customers’ demand for head-to-toe protection by supplementing our existing products with those from third-party vendors from varied locations.
(2) Use of e-commerce platforms and data analysis to source for potential customers and new vendors. 
(3) Leveraging the corporate brand and the overall goodwill and trust in the Group, which was strengthened as the COVID-19 crisis progressed, to develop the Group’s own CoverU line of PPE. (Note: The percentage of sales of own label products in the first three quarters of 2020 has exceeded 68% of the Group’s total sales). 
(4) Securing recurring orders and cultivating long-term relationships with customers.

Stay home and stay safe everyone.
Heart
Reply
#1
Rainbow 
3Q result as at 30 Sep 2020
Revenues      USD287m (vs  50m)
Gross Profit  USD116m (vs  7m)
Net Profit    USD 84m (vs 0.4m)

Critical success factors

(1) Implementation of the "Source and Sell Globally" strategy to provide one-stop, bundled services to meet our customers’ demand for head-to-toe protection by supplementing our existing products with those from third-party vendors from varied locations.
(2) Use of e-commerce platforms and data analysis to source for potential customers and new vendors. 
(3) Leveraging the corporate brand and the overall goodwill and trust in the Group, which was strengthened as the COVID-19 crisis progressed, to develop the Group’s own CoverU line of PPE. (Note: The percentage of sales of own label products in the first three quarters of 2020 has exceeded 68% of the Group’s total sales). 
(4) Securing recurring orders and cultivating long-term relationships with customers.

Stay home and stay safe everyone.
Heart
Reply
#2
(14-10-2020, 08:55 AM)¯|_(ツ)_/¯ Wrote: 3Q result as at 30 Sep 2020
Revenues      USD287m (vs  50m)
Gross Profit  USD116m (vs  7m)
Net Profit    USD 84m (vs 0.4m)

Critical success factors

(1) Implementation of the "Source and Sell Globally" strategy to provide one-stop, bundled services to meet our customers’ demand for head-to-toe protection by supplementing our existing products with those from third-party vendors from varied locations.
(2) Use of e-commerce platforms and data analysis to source for potential customers and new vendors. 
(3) Leveraging the corporate brand and the overall goodwill and trust in the Group, which was strengthened as the COVID-19 crisis progressed, to develop the Group’s own CoverU line of PPE. (Note: The percentage of sales of own label products in the first three quarters of 2020 has exceeded 68% of the Group’s total sales). 
(4) Securing recurring orders and cultivating long-term relationships with customers.

Stay home and stay safe everyone.
Heart

There is indeed a big jump in the top and bottom line. But questions remain whether the number is repeatable especially when the pandemic becomes less of a problem when a effective vaccine is finally in the market. 
Not forgetting that this was once a penny stock right?
Reply
#2
(14-10-2020, 08:55 AM)¯|_(ツ)_/¯ Wrote: 3Q result as at 30 Sep 2020
Revenues      USD287m (vs  50m)
Gross Profit  USD116m (vs  7m)
Net Profit    USD 84m (vs 0.4m)

Critical success factors

(1) Implementation of the "Source and Sell Globally" strategy to provide one-stop, bundled services to meet our customers’ demand for head-to-toe protection by supplementing our existing products with those from third-party vendors from varied locations.
(2) Use of e-commerce platforms and data analysis to source for potential customers and new vendors. 
(3) Leveraging the corporate brand and the overall goodwill and trust in the Group, which was strengthened as the COVID-19 crisis progressed, to develop the Group’s own CoverU line of PPE. (Note: The percentage of sales of own label products in the first three quarters of 2020 has exceeded 68% of the Group’s total sales). 
(4) Securing recurring orders and cultivating long-term relationships with customers.

Stay home and stay safe everyone.
Heart

There is indeed a big jump in the top and bottom line. But questions remain whether the number is repeatable especially when the pandemic becomes less of a problem when a effective vaccine is finally in the market. 
Not forgetting that this was once a penny stock right?
Reply
#3
The top and bottom line improvement definitely looks impressive. But question remain if such numbers are repeatable especially when the pandemic becomes less of a problem when a effective vaccine is in the market.
Reply
#3
The top and bottom line improvement definitely looks impressive. But question remain if such numbers are repeatable especially when the pandemic becomes less of a problem when a effective vaccine is in the market.
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)